OpenAI Funding Target Cut to $20B at $1.25 Trillion Valuation

From $1.4 trillion to $1.25 trillion in a month

At the end of September, OpenAI looked set to make another record-breaking private raise. Bloomberg reported that the ChatGPT maker was seeking at least $30 billion at a pre-money valuation of about $1.4 trillion. The round was presented as a bridge to stand in for an initial public offering that CEO Sam Altman had postponed.14 Thirty days later, that target has shrunk. On October 30 the Financial Times reported that OpenAI had lowered its goal by $10 billion, to about $20 billion, and cut its desired valuation to $1.25 trillion. A sell-off in AI-linked technology stocks was weighing on investor demand.36 The FT also said the company had set that Friday as the deadline for commitments, and that the "first close" was expected to come in under $20 billion because some investors had trimmed their allocations.38 The Wall Street Journal put commitments at about $11 billion, which is less than half of the original $30 billion ask.

The headline number is still enormous. Even so, the direction has reversed. For two years, OpenAI's private marks have only gone up, and they have served as the reference price for the whole frontier-AI market. The clearest reading of this round is that it marks the first time investor discipline has visibly pushed back on that price.

How the round was built

The raise looked unusual from the start. Bloomberg's sources said the talks were early and that investors, not OpenAI, were driving demand, drawn by the company's revenue momentum.4 Within a week, a structure had emerged. OpenAI was talking to a syndicate of UAE funds, led by Abu Dhabi's MGX, that had discussed putting in as much as $10 billion. BlackRock was also in talks to join.34 OpenAI offered the $1.4 trillion valuation as a fixed price even though it had no lead investor, which skipped the usual step where a lead negotiates terms.343 Existing backers Thrive Capital and Andreessen Horowitz were reported to be in discussions, as was the University of California's endowment.3

When a company sets its own price without a lead, it is betting that demand will absorb whatever number it names. That bet held for roughly three weeks. Around October 22, CNBC and Bloomberg reported that the valuation under discussion had already slipped to $1.25 trillion, while the $30 billion size still stood and Coatue had joined the UAE investors as a possible co-lead.37 The FT story eight days later cut the size as well.36 By that point, MGX's consortium was expected to be the largest participant, with Founders Fund, Coatue, Sequoia Capital and Andreessen Horowitz also expected to take part.38

One detail points to where the leverage now sits. Under the deal, OpenAI would get an option to lease newly built computing capacity in the UAE.36 When the biggest check comes with compute access attached, the round starts to look less like a pure venture investment and more like a strategic capacity arrangement. That probably explains why the raise is getting smaller instead of falling apart. Wealthy individuals are also due to get a later retail offering at the same $1.25 trillion valuation, which shows OpenAI is widening its pool of buyers.38

The revenue story depends on who is counting

The case for the valuation rests on growth, and the reported figures do not line up. Bloomberg put OpenAI's annualized revenue above $40 billion and said it had grown 70% since July.1 Axios, with confirmation from Reuters, reported a run rate approaching $70 billion, up more than 70% since the start of the third quarter, with enterprise sales more than doubling.510 Other Reuters reporting put September's annualized figure close to $50 billion.37 Depending on which number you use, the original $1.4 trillion ask works out to anything from about 20 times run-rate revenue to about 35 times.539

The gap matters. If OpenAI really is approaching $70 billion, the cut to $1.25 trillion is a modest re-rating of a company growing quickly. If the true figure is closer to $40 billion, investors had good reason to resist. Some details lean toward caution. Earlier this year OpenAI missed its own revenue and user targets. The Wall Street Journal reported that CFO Sarah Friar warned colleagues that slow growth could leave the company unable to meet future computing contracts.1 Fortune reported Q2 revenue of $6.7 billion along with an operating loss, and the FT reported that OpenAI spent $34 billion last year.39 OpenAI has also reduced some usage allowances on its $200 subscription tier while launching a $500 tier and an always-on agent called Dots.12 Taken together, these moves look more like a company working to improve unit economics than one confident about them.

Safety as the reason for delay, and as cover

OpenAI has framed the IPO delay in unusually stark language. Altman called a 2026 listing "ill-advised" while the company works through safety issues.1 He told Bloomberg TV that OpenAI wants to adapt to a "new level" of AI capability without the pressure of being newly public.4 He also told Fortune that taking "a 10% chance of killing everybody by the end of the decade" was unacceptable.6 In the same week the round was first reported, OpenAI said it would hold back its newest model, GPT-6.1 Astra, after it failed the company's internal safety bar.1

The safety concerns may be entirely real. Still, the financial context gives the delay a second explanation. The Journal reported that Friar had already questioned whether OpenAI could meet public-market regulatory requirements on Altman's preferred schedule.1 Some of OpenAI's existing money also comes with conditions. Amazon agreed to invest $50 billion, but $35 billion of that reportedly depends on OpenAI going public or reaching an AGI milestone.5 Delaying the listing therefore keeps a large commitment uncertain, which helps explain why a bridge round became urgent.

Anthropic sets the benchmark

The competitive picture explains the timing. Anthropic overtook OpenAI in May with a $65 billion Series H at a $965 billion post-money valuation. The round was led by Altimeter, Dragoneer, Greenoaks and Sequoia, and it was the first time Anthropic had been valued above its rival.2226 It filed confidentially for an IPO on June 1 and filed publicly on October 26 for a Nasdaq listing under the ticker ANT.2129 Its debut is expected in mid-November. Reuters reported that Anthropic has been targeting an IPO valuation above $2 trillion.25 More recent Bloomberg reporting put investors' view of fair value at about $1.4 trillion to $1.5 trillion.

According to Reuters, OpenAI wanted to close its round before that listing because both companies are drawing on a similar pool of investors.38 PitchBook analyst Harrison Rolfes described OpenAI's position differently, saying the company holds "a free option" to see how institutions respond to audited frontier-AI financials before setting its own public price.5 Both accounts can be true, but the past month favors the first. If OpenAI had been comfortable waiting, it would not have set a commitment deadline in the middle of a sell-off. A firm reference price from Anthropic's IPO could easily come in below OpenAI's private mark, and that risk gives OpenAI good reason to lock in a valuation now.

The market backdrop made the deadline harder. The Nasdaq dropped 2.9% on October 30 and ended about 7.8% below its October 6 record close. The sell-off was concentrated in AI-exposed stocks, amid growing concern about capital spending.35

What it means for the rest of AI venture capital

Away from the trillion-dollar labs, AI dealmaking has not slowed. One tracker counted 105 AI rounds totaling $43.6 billion in October through the 26th.15 TypeSafe AI raised an $870 million Series A at $7.5 billion, led by Andreessen Horowitz, after being valued at about $200 million less than a month before. Arena nearly doubled its valuation to $3.1 billion.14 Flapping Airplanes raised a $1 billion Series A, Legora raised $550 million, and Cohere announced a first close on a Series E targeting up to C$7 billion.1319

That activity sits on top of the frontier labs' valuations, and OpenAI's mark is the main reference point. An earlier analysis warned that if the round ended up smaller or at a lower price, it would "reset comps" for every private AI raise waiting behind it.6 That has now happened, though only partly. A $150 billion cut still leaves $1.25 trillion, roughly 47% above March's $852 billion post-money figure.37 Because the round shrank faster than the valuation, existing shareholders also face less dilution.35

The overall picture holds together. Investors have not stopped believing in OpenAI. They have stopped paying whatever price it sets. For unicorns pricing growth rounds off frontier-lab multiples, that difference matters most. The next real test of AI valuations will come from Anthropic's share price in November, not from OpenAI's private round.